Cabot (CBT)
(Delayed Data from NYSE)
$110.86 USD
-0.91 (-0.81%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $110.92 +0.06 (0.05%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$110.86 USD
-0.91 (-0.81%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $110.92 +0.06 (0.05%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth C Momentum A VGM
Zacks News
Zacks Industry Outlook Highlights Air Products and Chemicals, DuPont de Nemours, Albemarle and Cabot
by Zacks Equity Research
Air Products and Chemicals, DuPont de Nemours, Albemarle and Cabot are part of the Zacks Industry Outlook article.
4 Diversified Chemical Stocks to Escape Industry Challenges
by Anindya Barman
Demand worries due to weakness in certain markets and raw material cost inflation pose headwinds for the Zacks Chemicals Diversified industry. APD, DD, ALB and CBT are poised to navigate the industry challenges.
Cabot (CBT) to Unveil Battey Application Center in Europe
by Zacks Equity Research
The new technology center will allow Cabot (CBT) to enhance its battery materials development capabilities.
Cabot's (CBT) Earnings and Revenues Outshine Estimates in Q1
by Zacks Equity Research
Cabot's (CBT) Q1 performance reflects a decline in volumes due to consumer destocking and COVID-19 outbreaks in China. Weak demand and unfavorable currency movements also played a role.
Cabot (CBT) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 2.08% and 11.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Cabot (CBT) to Boost CCA Capacity to Support EV Transition
by Zacks Equity Research
Cabot's (CBT) investment in Carbon additives is expected to solidify its position as a leading producer of CCAs for lithium-ion battery applications.
Why Is Cabot (CBT) Up 2% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot's (CBT) Earnings and Sales Surpass Estimates in Q4
by Zacks Equity Research
Cabot's (CBT) results were aided by higher margins and stronger volumes in the fiscal fourth quarter.
Cabot (CBT) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 4.73% and 7.16%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Huntsman (HUN) Matches Q3 Earnings Estimates
by Zacks Equity Research
Huntsman (HUN) delivered earnings and revenue surprises of 0% and 1.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Kronos Worldwide (KRO) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Kronos Worldwide (KRO) delivered earnings and revenue surprises of -51.35% and 10.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Univar (UNVR) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Univar (UNVR) delivered earnings and revenue surprises of 12% and 1.88%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cabot's (CBT) Shares Up 17% YTD: What's Driving the Stock?
by Zacks Equity Research
Cabot (CBT) gains on strong underlying demand across its businesses, its disciplined execution of operations and strategic acquisition.
5 Top-Notch Dividend Plays in the Diversified Chemical Industry
by Anindya Barman
Against the current volatile macroeconomic backdrop, it would be prudent to add some top-quality dividend-paying chemical stocks in your portfolio. CC, CBT, HUN, LYB and TROX fit the bill.
Cabot (CBT) Down 1.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot (CBT) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
Cabot (CBT) Up 11% in 3 Months: What's Driving the Stock?
by Zacks Equity Research
Solid fiscal third quarter results and upbeat outlook have contributed to the run-up in Cabot's (CBT) shares.
Pan American Silver (PAAS) Q2 Earnings & Sales Miss Estimates
by Zacks Equity Research
Pan American Silver (PAAS) reports a loss for Q2 due to lower silver prices. Management maintains silver production guidance between 19 million ounces and 20.5 million ounces for 2022.
Franco-Nevada (FNV) Q2 Earnings & Sales Beat Estimates, Up Y/Y
by Zacks Equity Research
Franco-Nevada's (FNV) Q2 top-line results benefit from higher realized oil and gas prices.
Cabot's (CBT) Earnings and Sales Surpass Estimates in Q3
by Zacks Equity Research
Cabot (CBT) gains on higher margins and stronger volumes across the board in the fiscal third quarter.
Veritiv (VRTV) Surpasses Q2 Earnings Estimates, Hikes '22 View
by Zacks Equity Research
Veritiv's (VRTV) Q2 results gain from double-digit sales growth and year-over-year adjusted EBITDA margin improvements across each segment.
Endeavour Silver (EXK) Q2 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Endeavour Silver (EXK) reports soft revenues and a loss for Q2, mainly due to its decision to hold a certain amount of silver in its inventory amid the prevailing lower silver prices.
Comstock Mining (LODE) Q2 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Comstock Mining (LODE) reported a loss per share of 20 cents for the second quarter of 2022 due to higher research and development expenditures, and changes in fair values of derivatives.
Great Panther (GPL) Q2 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Great Panther (GPL) reports a second-quarter 2022 loss on lower metal sales volumes and inflationary pressures, somewhat offset by higher metal prices.
Hecla Mining (HL) Q2 Earnings Beat Estimates, Revenues Lag
by Zacks Equity Research
Hecla Mining (HL) reports a year-on-year decline in both earnings and revenues in Q2 on lower metal prices, while production improved 3% year on year.